322 related articles for article (PubMed ID: 11895469)
1. Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions.
Trovati M; Ponziani MC; Massucco P; Anfossi G; Mularoni EM; Burzacca S; Tassone F; Perna P; Traversa M; Cavalot F
Eur J Clin Invest; 2002 Mar; 32(3):179-86. PubMed ID: 11895469
[TBL] [Abstract][Full Text] [Related]
2. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
3. Relationship between diurnal glucose levels and HbA1c in type 2 diabetes.
Pistrosch F; Koehler C; Wildbrett J; Hanefeld M
Horm Metab Res; 2006 Jul; 38(7):455-9. PubMed ID: 16933182
[TBL] [Abstract][Full Text] [Related]
4. [The features of postprandial glucose state in type 2 diabetes mellitus].
Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538
[TBL] [Abstract][Full Text] [Related]
5. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
[TBL] [Abstract][Full Text] [Related]
6. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
Galic E; Vrtovec M; Bozikov V; Schwarzenhofer M; Milicevic Z
Med Sci Monit; 2005 Dec; 11(12):PI87-92. PubMed ID: 16319804
[TBL] [Abstract][Full Text] [Related]
7. Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.
Peter R; Dunseath G; Luzio SD; Owens DR
Diabetes Metab; 2013 Sep; 39(4):337-42. PubMed ID: 23993831
[TBL] [Abstract][Full Text] [Related]
8. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
9. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.
Wang JS; Tu ST; Lee IT; Lin SD; Lin SY; Su SL; Lee WJ; Sheu WH
Diabetes Metab Res Rev; 2011 Jan; 27(1):79-84. PubMed ID: 21218511
[TBL] [Abstract][Full Text] [Related]
10. Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
Kovatchev BP; Crean J; McCall A
Diabetes Technol Ther; 2008 Oct; 10(5):391-6. PubMed ID: 18715216
[TBL] [Abstract][Full Text] [Related]
11. Effect of carbohydrate distribution on postprandial glucose peaks with the use of continuous glucose monitoring in type 2 diabetes.
Pearce KL; Noakes M; Keogh J; Clifton PM
Am J Clin Nutr; 2008 Mar; 87(3):638-44. PubMed ID: 18326602
[TBL] [Abstract][Full Text] [Related]
12. Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes.
Zhou J; Jia W; Bao Y; Ma X; Lu W; Li H; Hu C; Xiang K
Med Sci Monit; 2008 Nov; 14(11):CR552-8. PubMed ID: 18971871
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin.
Bonomo K; De Salve A; Fiora E; Mularoni E; Massucco P; Poy P; Pomero A; Cavalot F; Anfossi G; Trovati M
Diabetes Res Clin Pract; 2010 Feb; 87(2):246-51. PubMed ID: 19954855
[TBL] [Abstract][Full Text] [Related]
14. Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes.
Monnier L; Colette C; Rabasa-Lhoret R; Lapinski H; Caubel C; Avignon A; Boniface H
Diabetes Care; 2002 Apr; 25(4):737-41. PubMed ID: 11919134
[TBL] [Abstract][Full Text] [Related]
15. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
[TBL] [Abstract][Full Text] [Related]
16. [Glycemic excursions in people with normal glucose tolerance in Chengdu].
He LP; Wang C; Zhong L; Yang YZ; Long Y; Zhang XX; Shu SQ; Yu HL; Yu TT; Wang WP; Wang Y; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):704-7. PubMed ID: 19764578
[TBL] [Abstract][Full Text] [Related]
17. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.
Bellomo Damato A; Stefanelli G; Laviola L; Giorgino R; Giorgino F
Diabet Med; 2011 May; 28(5):560-6. PubMed ID: 21204958
[TBL] [Abstract][Full Text] [Related]
18. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
19. Continuous glucose monitoring and cognitive performance in type 2 diabetes.
Pearce KL; Noakes M; Wilson C; Clifton PM
Diabetes Technol Ther; 2012 Dec; 14(12):1126-33. PubMed ID: 23046398
[TBL] [Abstract][Full Text] [Related]
20. Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial.
Su Q; Liu J; Li P; Qian L; Yang W
Diabetes Ther; 2018 Jun; 9(3):987-999. PubMed ID: 29574635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
